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INTRODUCTION 
In an effort to identify a cohort of patients who might 
benefit from the early administration of novel therapies 
designed to modulate the endogenous host inflam- 
matory response, an expert consensus conference of the 
American College of Chest Physicians and the Society 
of Critical Care [1] coined the phrase systemic inflam- 
matory response syndrome (SIRS) to describe a clinical 
syndrome believed to be the result of an overly 
activated inflammatory response. This new definition 
recognized the important role that endogenous media- 
tors of systemic inflammation play in sepsis, which was 
no longer regarded as being caused by microbial 
pathogenicity factors alone [2]. 
The clinical signs of sepsis, such as fever, 
tachycardia, tachypnea and leucocytosis, are common 
responses to systemic infection. A trigger-response 
concept of sepsis emerged, in which bacteria were seen 
as the trigger, with the pathophysiology being the 
response to that trigger. It was now recognized that 
sepsis involved both microbial and pathophysiological 
events, and this powerful concept allowed clinicians to 
see the role of infection in the common inflammatory 
response 121. For example, uninfected trauma patients 
and those with intra-abdominal infection had similar 
clinical courses, both groups developing multiple organ 
failure with identical microscopic pathology [3] - 
autodestructive inflammation which seemed to be 
independent of infection. Also, in animal studies it was 
found that the severity of the physiological response 
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was a better predictor of outcome than the microbial 
challenge [4]. 
THE CONSENSUS CONFERENCE DEFINITION 
FOR SIRS AND MODS 
The criteria proposed by the ACCP/SCCM are given 
in Table 1. Two or more criteria are needed for meeting 
the definition of systemic inflammatory response syn- 
drome (SIRS). There are differences with previous 
definitions; as can be seen in Table 2 the definition of 
sepsis syndrome by Bone et al [5] has a more rigorous 
definition than severe sepsis, requiring the presence of 
three screening criteria (as opposed to any two of four 
in SIRS but, for purposes of clinical study, the two have 
been considered equivalent [6]). 
It is recognized that there is a progression in the 
disease state from SIRS/sepsis to severe SIRS/severe 
Table 1 Systemic inflammatory respose syndrome (SIRS) 
Two or more 
(1) Temperature >38"C or < 3 6 T  
(2) Heart rate >90/min 
(3) Respiratory rate >20 min 
or 
Pa PCO2 <32 torr 
(4) WBC > 12.000 cells/mm3, <4.000 cells/mm3 
ACCP/SCCM, 1992 (1). 
or < 10% band forms 
Table 2 Sepsis syndrome 
Clinical evidence of infection 
Rectal temperature >38.3" or <35.6"C 
Respiratory rate >20/min 
Heart rate >90/min 
One of the following: Alteration in mental status 
Hypoxemia (Pa02 <72 torr) 
Oliguria (<30 ml/hour) 
Data from Bone et al [5]. 
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sepsis in the presence of acute organ dysfunction, 
hypotension or hypoperfusion. The next step in the 
progression is sterile shock/septic shock present when 
there is hypotension that is unresponsive to resuscita- 
tion with fluids. 
Multiple organ dysfunction syndrome (MODS) is 
the recognized diminished organ dysfunction associated 
with acute illness, in which organ function is not 
capable of maintaining homeostasis. The dyshnction 
can be absolute or relative but is more ready identified 
as a gradual change over time. When several organs fail 
to maintain their function, MODS can be said to have 
complicated the SIRS. The various stages must be seen 
as phases in a continuum of increasing disturbance of 
homeostasis. Although these definitions were not 
meant to represent prognostic indicators, an index of 
the usefulness of the syndrome definitions could be 
related to morbidity and mortality, independently for 
age and underlying disease, so that patients with these 
syndromes would be more sick and more likely to die 
than patients without [1,7,8]. 
Several scoring systems have been introduced to 
assess the physiologic response, but the variables must 
be weighted carefully so that increasing score values 
correlate with worsening prognosis. Examples of such 
scoring methods are the acute physiology and chronic 
health evaluation (APACHE) [9], the simplified acute 
physiologic score (SAPS 11) [lo] and the mortality 
probability model (MPM 11) [ll]. The Apache system 
is the most widely used system for assessing acute 
physiologic disturbances. The pathophysiology scored 
is that which predicts the greater mortality risk in 
patients with differing initiating events or diagnoses. 
The latest version, APACHE 111, provides updated risk 
assessment for the first seven days of illness [12]. 
Mild degrees of organ dysfunction are common in 
SIRS but the untreated patients may develop severe 
organ failure, which is associated with poor outcome. 
The simultaneous failure of two organs is associated 
with widely differing prognosis depending on the 
combination of organs involved, ranging from 20% 
mortality for combined cardiovascular and haemato- 
logical failure to 76% mortality for combined cardio- 
vascular and central nervous system failure [13]. 
The various methods of grading organ dysfunction 
have been recently reviewed for the development of a 
new score of organ failure. This MOD score considers 
six organ systems [14] (Table 3). The function of each 
organ is weighted on a scale from 0 to 4. The weighting 
was developed in one half of a surgical ICU population 
and validated in the other half. For each variable a 0 
value was associated with < 5% mortality while a value 
of 4 represented severe dysfunction and a mortality of 
>50% for patients managed in the ICU. 
Table 3 MOD scorea 
System Parameter 0 4 
Respiratory P(Oz)/FI(Oz) ratio >300 575  
Renal Serum creatinine (pmol/L) 5100 2500 
Hepatic Serum bilirubin (pnol/L) 5 2 0  >240 
Cardiovascular PARb 510 >30 
Hematological Platelet count 
Neurological Glasgow coma S 15 5 6  
'Adapted from Marshall et a1 [14]. 
bPressure-adjusted heart rate: Heart rate X (R atrial pressure/mean 
arterial pressure). 
THE MEDIATORS 
After an injection of bacteria or endotoxin, certain 
cytokines appear briefly in circulating blood. The 
classical sequence is tumor necrosis factor alfa (TNF 
alfa) followed by interleukins 1 (IL-l), 6 (IL-6) and 8 
(IL-8). These cytokines have been named the pro- 
inflammatory or alarm cytokines because they appear 
first. They, and other factors, mediate various responses 
including the activation of numerous cell populations 
and release of secondary cytokines and growth factors. 
It is important to understand whether the same 
mediator is activated by different triggers and if 
different mediators are associated with different patho- 
physiological responses. Does the pathophysiological 
response to infection differ from the response to other 
triggers? There are certain differences: infection induces 
more TNF alfa than does physical trauma, which 
releases more IL-6 and IL-8 [2]. Thus primary infection 
is associated with higher fever than in trauma, probably 
because of the different balance of memators produced. 
Hypovolemic and hypotensive patients, however, often 
suffer initially from hypothermia and leucopenia 
whether triggered by infection or trauma. Initial 
differences in mediator pattern result in different 
clinical presentations, but within hours or days it is 
clinically no longer possible to associate these responses 
with specific triggers [2]. 
Approaching the problem from a different stand- 
point, attempts to correlate measurements of circulating 
cytokines with pathophysiological changes and with 
prognosis have not been entirely successful. The 
concentrations of these mediators vary very widely 
probably because they have short half-lives in the 
circulation and most are localized within the inflamed 
body compartments where they cannot readily be 
measured [2]. 
THE ACUTE PHASE RESPONSE 
This may be seen as the primary part of the systemic 
inflammatory response. The principal alarm cytokines 
G a r a u :  N e w  c o n c e p t s  o f  s e p s i s  a n d  t h e i r  p r a c t i c a l  v a l u e  2 S 1 5  
cause fever and stimulate the pituitary to release stress 
hormones. They also stimulate the liver to synthesize a 
number of acute phase proteins such as C-reactive 
protein, fibrinogen and major anti-proteases [15]. IL-6 
is the principal signal for the hepatic acute phase 
response. At the site of injury numerous mediators 
cause pain, vasodilatation and increased vascular perme- 
ability, and attract granulocytes to the site. 
The acute phase response involves additional mech- 
anisms which reverse the inflammatory response. IL-4 
and IL-10 can turn off monocyte-macrophage 
production of T N F  alfa, IL-I, IL-6 and IL-8, and 
therefore have potent anti-inflammatory action. In 
addition the acute phase response produces antagonists 
to the T N F  receptor and IL-1 receptor, which bind the 
circulating cytokine or block receptors on target cells. 
The early events also induce the production of 
cortisone. Through the combined action of these 
mechanisms and others the acute phase response is 
attenuated and the homeostasic mechanisms return to 
normal. This process takes several days and it is best 
seen in patients after major surgery. Fever resolves after 
two to three days, bowel function is restored after three 
to four days and the patient can soon return to full oral 
intake. The extent of the pro- and anti-inflammatory 
events is proportional to the magnitude of the insult. 
Constitutional factors, both genetic and acquired, may 
cause particular patients to overreact or respond 
inadequately. The pro- and anti-inflammatory mech- 
anisms are often disregulated for reasons that are poorly 
understood [2]. 
LIMITATIONS OF THE NEW DEFINITIONS OF SEPSIS 
The above definitions have allowed some uniformity 
necessary to deepen insight into the epidemiology of 
the systemic inflammatory response, but the usefulness 
of the criteria for these definitions remains unproved. 
SIRS is too sensitive and not specific; examples of 
this oversensitivity are ‘running for the bus’ and ‘the flu’ 
[I61 and it is clear that they should not be applied in 
the absence of clinical judgement. The definitions of 
sepsis have failed to identify a subgroup with an 
increased risk of death and, in fact, they have not been 
helpful in clinical practice nor in clinical trial design 
[16l. 
In some studies 1171, the frequency of positive 
microbiological results did not increase with an 
increasing number of SIRS criteria; the increasing 
mortality could be attributed to a more harmful 
response rather than to a higher frequency of infection. 
In other populations [18], SIRS criteria appear to be 
little more than abbreviated generic severity scores of 
illness measure - a variation on APACHE I1 or the 
Injury Severity Scoring System - and this observation 
should be expected: the four physiologic variables that 
define SIRS (tachycardia, tachypnea, hyper-or hypo- 
thermia, and leucocytosis or leucopenia) are all com- 
ponents of APACHE 11, as are acidosis, altered 
mentation, and hypotension, which are variables that 
characterize severe sepsis and septic shock [19]. 
The definition of ‘sepsis syndrome’ as originally 
defined by Bone et a1 [5], prior to the consensus 
definitions, included alterations in mental status as a 
criterion. Bossink et al’s data [17] confirmed than 
mental changes may be early clinical features of 
infection and they could be reintroduced, by virtue of 
their prognostic value, in the sepsis definitions. SIRS 
and sepsis definitions could be further refined to 
include hypoalbuminemia to improve the ability of 
identieing febrile patients who have a harmful host 
response to infection [17]. The prospect of discrimina- 
ting the maladaptive consequences of the host response 
from its beneficial effects remains elusive [19] and more 
research would be necessary to better define a patient 
group likely to respond to a treatment intervention in 
a predictable and useful manner [20]. 
Table 4 Diagnostic and prognostic value of plasma 
procalcitonin (PCT) levels in sepsis 
Daily plasma measurements m I C U  patients 
SIRS S ss Sh 
n = 1 8  n=14 n=21 n=25 
PCT2 0.6 3.5 6.2 21.3 
ICU mortahty 28% 14% 19% 64% 
S: sepsis; SS: severe sepsis; Sh: septic shock. 
”Values on admission (day 1). 
Data from Pugin et a1 1211. 
Despite these negative views concerning the 
clinical value of the new definitions of sepsis, studies 
continue to show interest in using them; a recent report 
on the diagnostic and prognostic value of plasma pro- 
calcitonin levels in human sepsis, appears to revalidate 
the utility of the definition of SIRS and sepsis: in a 
group of 78 intensive care patients prospectively 
followed (Table 4), no difference in clinical variables 
was observed between SIRS and septic patients. Pro- 
calcitonin levels, however, had a 97% sensitivity and a 
78% specificity in differentiating patients with SIRS 
from those with sepsis. Also, all patients who died never 
had procalcitonin levels below 1.1 n g / d  [21]. 
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